Vascular protection with rivaroxaban in the comprehensive management of atrial fibrillation-Reference-Cited by-同舟云学术

Vascular protection with rivaroxaban in the comprehensive management of atrial fibrillation

Published:2023-11-02 Issue:11 Volume:21 Page:791-802
ISSN:1477-9072
Container-title:Expert Review of Cardiovascular Therapy
language:en
Short-container-title:Expert Review of Cardiovascular Therapy

Author:

Escobar-Cervantes Carlos¹,Díez-Villanueva Pablo²,Bonanad Lozano Clara³⁴⁵,Reino Antonio Pose⁶,Almendro-Delia Manuel⁷,Facila Lorenzo⁸,Valle Alfonso⁹,Suárez Carmen¹⁰

Affiliation:

1. Cardiology Department, Hospital La Paz, Madrid, Spain

2. Cardiology Department, Hospital Universitario de La Princesa, Madrid, Spain

3. Cardiology Department, Hospital Clínico Universitario de Valencia, Valencia, Spain

4. Medicine Department, Faculty of Medicine of the University of Valencia, Valencia, Spain

5. Cardiology Section, Instituto de Investigación Sanitaria del Hospital Clínico de Valencia (INCLIVA), Spain

6. Hypertension and Vascular Risk Unit, Internal Medicine Service, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain

7. Intensive Cardiovascular Care Unit, Cardiovascular Clinical Trials & Translational Research Unit, Cardiology and Cardiovascular Surgery Division, Virgen Macarena University Hospital, Sevilla, Spain

8. Cardiology Department, Hospital General de Valencia, Universitat de Valencia Valencia, Spain

9. Cardiology department, Hospital de Denia, Alicante, Spain

10. Internal Medicine Service, Hospital Universitario de La Princesa, Madrid, Spain

Funder

Bayer Hispania SL

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,General Medicine,Internal Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14779072.2023.2276893

Reference103 articles.

1. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

2. Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

3. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials

4. Anticoagulantes orales directos frente a antagonistas de la vitamina K en pacientes con fibrilación auricular de la práctica clínica: revisión sistemática y metanálisis

5. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research Progress in Bleeding Caused by Rivaroxaban in Patients with Atrial Fibrillation;Advances in Clinical Medicine;2023